TRIP13, identified as a hub gene of tumor progression, is the target of microRNA-4693-5p and a potential therapeutic target for colorectal cancer

Colorectal cancer (CRC) is one of the digestive tract malignancies whose early symptoms are not obvious. This study aimed to identify novel targets for CRC therapy, especially early-stage CRC, by reanalyzing the publicly available GEO and TCGA databases. Thyroid hormone receptor interactor 13 (TRIP1...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan, Chen, Danqi, Qin, Ying, Qiu, Cheng, Zhou, Yaoyao, Dai, Mengmeng, Li, Lulu, Sun, Qinsheng, Jiang, Yuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786872/
https://www.ncbi.nlm.nih.gov/pubmed/35075117
http://dx.doi.org/10.1038/s41420-022-00824-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786872/
https://www.ncbi.nlm.nih.gov/pubmed/35075117
http://dx.doi.org/10.1038/s41420-022-00824-w

Ejemplares similares